You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
貝康醫療(2170.HK):解禁流動性增強,股價見底迎“黃金坑”
格隆匯 08-23 11:44
格隆匯8月23日丨港股8月份迎市場解禁潮,其中就包括輔助生殖賽道的貝康醫療-B(2170.HK)。解禁作為資本市場一項比較重要的規則,對於上市不久的公司而言是一次重要的大考,在這一過程中,公司股價大都會在短期內面臨較大波動。不過,有分析人士指出,貝康醫療目前股價處於低位,隨着解禁後流通股數量增加,股票流動性增強,對於股價處於低位,且基本面較好的貝康醫療而言,解禁可以解讀成利好。建議投資者忽略短期擾動情緒,更應“風物長宜放眼量”。此前中金研報首次覆蓋即指公司是中國第三代試管嬰兒技術領航者,給予其跑嬴行業評級,目標價28.64港元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account